Prognosis and antibody profiles in survivors of critical illness from COVID-19: a prospective multicentre cohort study.

ABSTRACT:

Background

There is a need to assess the long-term outcomes of survivors of critical illness from COVID-19.

Methods

Ninety-two survivors of critical illness from COVID-19 from four hospitals in Hubei Province, China participated in this prospective cohort study. Multiple characteristics, including lung function (lung volumes, diffusing capacity for carbon monoxide, chest computed tomography scores, and walking capacity); immune status (SARS-CoV-2-neutralising antibody and all subtypes of immunoglobulin (Ig) G against SARS-CoV-2, immune cells in response to ex vivo antigen peptide stimuli, and lymphocyte count and its subtypes); liver, coagulation, and kidney functions; quality of life; cognitive function; and mental status, were assessed after 3, 6, and 12 months of follow-u

SUBMITTER: Yang X 

PROVIDER: S-EPMC8616737 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature